Mahyar Etminan, an epidemiologist at the University of British Columbia and senior author of the study, said up to two per cent of patients who used semaglutide and liraglutide medications to lose weight developed gastrointestinal problems
This is because, in animal studies, higher doses of semaglutide were found to increase the risk of developing thyroid C-cell tumors
[1] Failure to treat this disorder causes psychological damage and many social and economic complications for patients
Recent studies suggest that these agents act not only on peripheral incretin receptors but also within the central nervous system
In patients in whom the above-mentioned interventions are insufficient to control the manifestations of HF, additional mechanical circulatory support and/or cardiac transplantation may be indicated
Medical supervision ensures: Appropriate screening Proper dosing Monitoring for side effects Clear expectations Foundational Recovery Still Matters Whether or not you explore peptide therapy, your recovery depends heavily on the basics: Adequate protein intake (1.2 to 1.6 grams/kg of body weight) Proper hydration (drink fluids throughout the day, regularly check the color of your urine) Quality sleep (if sleep hygiene tactics dont work, address psychological and physiological factors)